Jingying Wu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jingying Wu has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
Ai Chen
Department of Geriatrics, The First Affiliated Hospital of Fujian Medical University, Fuzhou, People’s Republic of China
2 shared publicationsHuajun Wang
Department of Geriatrics, The First Affiliated Hospital of Fujian Medical University, Fuzhou, People’s Republic of China
2 shared publicationsLi Luo
Department of Geriatrics, The First Affiliated Hospital of Fujian Medical University, Fuzhou, People’s Republic of China
2 shared publications- Liangdi Xie
Department of Geriatrics, Fujian Hypertension Research Institute, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China
2 shared publications Siming Lin
Department of Geriatrics, The First Affiliated Hospital of Fujian Medical University, Fuzhou, People’s Republic of China
2 shared publicationsWeibin Wu
Department of Geriatrics, The First Affiliated Hospital of Fujian Medical University, Fuzhou, People’s Republic of China
2 shared publications
Latest Publications
- Open Access
A retrospective study of correlation between insulin resistance surrogate indexes, inflammatory markers, and peripheral arterial disease in type 2 diabetes mellitus
Background: This study aimed to investigate the correlation between six surrogate indexes of insulin resistance (IR) and six inflammatory markers with diabetic peripheral arterial disease (DPAD) in patients with type 2 diabetes mellitus (T2DM). Methods: Clinical and hematological data were retrospectively collected from 300 patients with T2DM admitted to the Endocrinology Department of Wuhu Hospital of Traditional Chinese Medicine (Anhui, China) between January 2024 and May 2025. Patients were divided into two groups: DPAD ( n = 207) and T2DM (without DPAD ( n = 93)). IR surrogate indexes analyzed included estimated glucose disposal rate (eGDR), Chinese Visceral Adiposity Index (CVAI), triglyceride-glucose (TyG) index, TyG-body mass index (TyG-BMI), metabolic score for insulin resistance (METS-IR), and atherogenic index of plasma (AIP). Inflammatory markers assessed included neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), total cholesterol-to-lymphocyte ratio (TCLR), fibrinogen-to-lymphocyte ratio (FLR), lymphocyte-to-monocyte ratio (LMR), and systemic immune-inflammation index (SII). Factors associated with DPAD were identified and the discriminative ability of IR surrogate indexes and inflammatory markers for DPAD was explored. Results: Compared with the T2DM group, the DPAD group exhibited significantly higher CVAI, TyG-BMI, METS-IR, AIP, NLR, PLR, TCLR, FLR, and SII ( p < 0.05), while eGDR and LMR were significantly lower ( p < 0.05). Logistic regression analysis revealed that CVAI, TyG-BMI, METS-IR, AIP, NLR, PLR, FLR, and SII were positively associated with DPAD, whereas eGDR and LMR were inversely associated. eGDR and FLR exhibited significant associations with DPAD in sex and age subgroups. Receiver operating characteristic (ROC) curve analysis revealed that the combined eGDR+CVAI+FLR+LMR model yielded the highest area under the ROC curve (AUC) of 0.742 (95% CI [0.681–0.803]). Conclusion: IR surrogate indexes and inflammatory markers are closely associated with DPAD risk in T2DM patients. The combined eGDR+CVAI+FLR+LMR model showed the best discriminative ability for DPAD, offering a potential reference for early clinical identification. These findings, however, are hypothesis-generating and require validation in prospective studies.
Open AccessA retrospective study of correlation between insulin resistance surrogate indexes, inflammatory markers, and peripheral arterial disease in type 2 diabetes mellitus
Background: This study aimed to investigate the correlation between six surrogate indexes of insulin resistance (IR) and six inflammatory markers with diabetic peripheral arterial disease (DPAD) in patients with type 2 diabetes mellitus (T2DM). Methods: Clinical and hematological data were retrospectively collected from 300 patients with T2DM admitted to the Endocrinology Department of Wuhu Hospital of Traditional Chinese Medicine (Anhui, China) between January 2024 and May 2025. Patients were divided into two groups: DPAD ( n = 207) and T2DM (without DPAD ( n = 93)). IR surrogate indexes analyzed included estimated glucose disposal rate (eGDR), Chinese Visceral Adiposity Index (CVAI), triglyceride-glucose (TyG) index, TyG-body mass index (TyG-BMI), metabolic score for insulin resistance (METS-IR), and atherogenic index of plasma (AIP). Inflammatory markers assessed included neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), total cholesterol-to-lymphocyte ratio (TCLR), fibrinogen-to-lymphocyte ratio (FLR), lymphocyte-to-monocyte ratio (LMR), and systemic immune-inflammation index (SII). Factors associated with DPAD were identified and the discriminative ability of IR surrogate indexes and inflammatory markers for DPAD was explored. Results: Compared with the T2DM group, the DPAD group exhibited significantly higher CVAI, TyG-BMI, METS-IR, AIP, NLR, PLR, TCLR, FLR, and SII ( p < 0.05), while eGDR and LMR were significantly lower ( p < 0.05). Logistic regression analysis revealed that CVAI, TyG-BMI, METS-IR, AIP, NLR, PLR, FLR, and SII were positively associated with DPAD, whereas eGDR and LMR were inversely associated. eGDR and FLR exhibited significant associations with DPAD in sex and age subgroups. Receiver operating characteristic (ROC) curve analysis revealed that the combined eGDR+CVAI+FLR+LMR model yielded the highest area under the ROC curve (AUC) of 0.742 (95% CI [0.681–0.803]). Conclusion: IR surrogate indexes and inflammatory markers are closely associated with DPAD risk in T2DM patients. The combined eGDR+CVAI+FLR+LMR model showed the best discriminative ability for DPAD, offering a potential reference for early clinical identification. These findings, however, are hypothesis-generating and require validation in prospective studies.
- Open Access
Integrated bioinformatics and single-cell analysis identifies vascular aging-related hub genes and immune drivers in atherosclerosis
Atherosclerosis (AS) is a chronic inflammatory disease closely linked to vascular senescence, yet the specific molecular mechanisms connecting aging processes to AS pathogenesis remain incompletely understood. This study integrated transcriptomic data from GEO datasets (GSE100927 and GSE43292) to identify vascular aging-related differentially expressed genes (VARDEGs). Following batch effect correction, 28 VARDEGs were screened and subjected to functional enrichment, protein-protein interaction (PPI) network analysis, and immune infiltration assessment. Seven hub genes ( MMP9, APOE, TNF, ICAM1, PPARG, CYBA, and NCF2 ) were identified and experimentally validated via qRT-PCR, confirming their significant upregulation in AS samples. Receiver operating characteristic (ROC) analysis demonstrated high diagnostic accuracy for six of these genes (AUC > 0.7), with TNF exhibiting superior performance. Immune infiltration analysis revealed profound alterations in 28 immune cell types, particularly monocytes and T cells, which correlated strongly with hub gene expression. Furthermore, single-cell RNA sequencing analysis (GSE184073) localized the expression of core genes predominantly to monocytes and T cells, highlighting TNF overexpression in T cells as a potential critical driver. Finally, molecular docking simulations suggested that curcumin exhibits strong binding affinity to these hub genes, particularly PPARG , providing a mechanistic basis for its therapeutic potential. Collectively, this study elucidates the landscape of vascular aging-related genes in AS, identifies novel diagnostic biomarkers, and proposes potential therapeutic targets involving immune modulation and natural compounds.
Open AccessIntegrated bioinformatics and single-cell analysis identifies vascular aging-related hub genes and immune drivers in atherosclerosis
Atherosclerosis (AS) is a chronic inflammatory disease closely linked to vascular senescence, yet the specific molecular mechanisms connecting aging processes to AS pathogenesis remain incompletely understood. This study integrated transcriptomic data from GEO datasets (GSE100927 and GSE43292) to identify vascular aging-related differentially expressed genes (VARDEGs). Following batch effect correction, 28 VARDEGs were screened and subjected to functional enrichment, protein-protein interaction (PPI) network analysis, and immune infiltration assessment. Seven hub genes ( MMP9, APOE, TNF, ICAM1, PPARG, CYBA, and NCF2 ) were identified and experimentally validated via qRT-PCR, confirming their significant upregulation in AS samples. Receiver operating characteristic (ROC) analysis demonstrated high diagnostic accuracy for six of these genes (AUC > 0.7), with TNF exhibiting superior performance. Immune infiltration analysis revealed profound alterations in 28 immune cell types, particularly monocytes and T cells, which correlated strongly with hub gene expression. Furthermore, single-cell RNA sequencing analysis (GSE184073) localized the expression of core genes predominantly to monocytes and T cells, highlighting TNF overexpression in T cells as a potential critical driver. Finally, molecular docking simulations suggested that curcumin exhibits strong binding affinity to these hub genes, particularly PPARG , providing a mechanistic basis for its therapeutic potential. Collectively, this study elucidates the landscape of vascular aging-related genes in AS, identifies novel diagnostic biomarkers, and proposes potential therapeutic targets involving immune modulation and natural compounds.
- Open Access
- 24 October 2025
- Published by Bentham Science Publishers Ltd. in Current Traditional Medicine
- Vol. 12, 1-16
Mechanistic Insights into Jianpi Recipe's Amelioration of Sarcopenia Via miRNA Modulation
Introduction: Sarcopenia, characterized by a significant decline in muscle mass and strength, poses a serious threat to the quality of life. Current treatment options are limited, necessitating the exploration of alternative therapeutic strategies. This study investigated the efficacy and mechanism of Jianpi Recipe (JPR), a traditional Chinese medicine formulation, in ameliorating Sarcopenia. Methods: This study employed a dexamethasone (DEX)-induced muscle atrophy mouse model to evaluate the efficacy of JPR. miRNA sequencing was conducted to identify differentially expressed miRNAs (DEmiRNAs). Enrichment analyses of target mRNAs were performed. The hub DEmiRNAs were identified by a Venn diagram and incorporated to construct a lncRNA-miRNA- mRNA ceRNA network. Finally, the hub DEmiRNAs were validated via RT-qPCR and correlation analysis. Results: JPR dose-dependently improved grip strength, muscle mass, and skeletal muscle histopathology. The miRNA sequencing identified 48 DEmiRNAs in the DEX vs. control group, as well as in the DEX and medium-dose JPR(DEX+M-JPR) vs. DEX group. Enrichment analyses revealed significant pathways, such as the Ras and Wnt signaling pathways, which are involved in the mechanisms underlying the efficacy of JPR. Nine hub DEmiRNAs were identified, with three (mmu-miR-423-3p, mmu-miR-328-3p, and mmu-miR-5621-3p) forming the ceRNA network. RT-qPCR showed that the expression levels of hub DEmiRNAs in control, DEX, and DEX+M - JPR groups were consistent with miRNA sequencing. Correlation analysis revealed a negative correlation between hub DEmiRNAs and relative grip strength and gastrocnemius muscle index. Discussion: This study clarified the protective effects of JPR against Sarcopenia and the mechanisms underlying miRNA modulation. Conclusion: JPR is suggested as a promising treatment for Sarcopenia.
- 24 October 2025
- Published by Bentham Science Publishers Ltd. in Current Traditional Medicine
- Vol. 12, 1-16
Open AccessMechanistic Insights into Jianpi Recipe's Amelioration of Sarcopenia Via miRNA Modulation
Introduction: Sarcopenia, characterized by a significant decline in muscle mass and strength, poses a serious threat to the quality of life. Current treatment options are limited, necessitating the exploration of alternative therapeutic strategies. This study investigated the efficacy and mechanism of Jianpi Recipe (JPR), a traditional Chinese medicine formulation, in ameliorating Sarcopenia. Methods: This study employed a dexamethasone (DEX)-induced muscle atrophy mouse model to evaluate the efficacy of JPR. miRNA sequencing was conducted to identify differentially expressed miRNAs (DEmiRNAs). Enrichment analyses of target mRNAs were performed. The hub DEmiRNAs were identified by a Venn diagram and incorporated to construct a lncRNA-miRNA- mRNA ceRNA network. Finally, the hub DEmiRNAs were validated via RT-qPCR and correlation analysis. Results: JPR dose-dependently improved grip strength, muscle mass, and skeletal muscle histopathology. The miRNA sequencing identified 48 DEmiRNAs in the DEX vs. control group, as well as in the DEX and medium-dose JPR(DEX+M-JPR) vs. DEX group. Enrichment analyses revealed significant pathways, such as the Ras and Wnt signaling pathways, which are involved in the mechanisms underlying the efficacy of JPR. Nine hub DEmiRNAs were identified, with three (mmu-miR-423-3p, mmu-miR-328-3p, and mmu-miR-5621-3p) forming the ceRNA network. RT-qPCR showed that the expression levels of hub DEmiRNAs in control, DEX, and DEX+M - JPR groups were consistent with miRNA sequencing. Correlation analysis revealed a negative correlation between hub DEmiRNAs and relative grip strength and gastrocnemius muscle index. Discussion: This study clarified the protective effects of JPR against Sarcopenia and the mechanisms underlying miRNA modulation. Conclusion: JPR is suggested as a promising treatment for Sarcopenia.
- Open Access
- 24 February 2023
- Published by Springer Nature in Cell Death Discovery
- Vol. 9 (1) , 1-15
TNF-α contributes to sarcopenia through caspase-8/caspase-3/GSDME-mediated pyroptosis
Sarcopenia has become a leading cause of disability and mortality in the elderly. It has been reported that programmed cell death (PCD) is associated with the development of sarcopenia that is characterized by reduction of muscle fiber size and number. TNF-α is also validated to play a prominent role in sarcopenia through its complex signaling pathways including cell death signaling. However, it is still unclear whether TNF-α contributes to sarcopenia by mediating pyroptosis, one type of PCD. Here, we first established naturally aged mice with sarcopenia model and confirmed an inflammatory state represented by TNF-α in aged mice. Evidence of GSDME-mediated pyroptosis and activation of apoptotic caspase-8/-3 were also found in skeletal muscle cells of aged mice with sarcopenia. We demonstrated that TNF-α triggered GSDME-mediated pyroptosis in myotubes through activating caspase-8 and caspase-3 by using caspase-8 and caspase-3 inhibitors. Comparing the activation of caspase-8 and GSDME expression between TNF Complex IIa and TNF Complex IIb, TNF-α was found to be more inclined to assemble TNF Complex IIb in activating caspase-8 and triggering pyroptosis. Moreover, pyroptotic myotubes were validated to result in decreased expression of MHC1 and finally loss of myotubes by knockdown of GSDME. Our work reveals a novel mechanism that TNF-ɑ/caspase-8/caspase-3/GSDME signaling-mediated pyroptosis contributes to the development of sarcopenia. Caspase-3/GSDME signaling-mediated pyroptosis may be a promising therapeutic target for sarcopenia.
- 24 February 2023
- Published by Springer Nature in Cell Death Discovery
- Vol. 9 (1) , 1-15
Open AccessTNF-α contributes to sarcopenia through caspase-8/caspase-3/GSDME-mediated pyroptosis
Sarcopenia has become a leading cause of disability and mortality in the elderly. It has been reported that programmed cell death (PCD) is associated with the development of sarcopenia that is characterized by reduction of muscle fiber size and number. TNF-α is also validated to play a prominent role in sarcopenia through its complex signaling pathways including cell death signaling. However, it is still unclear whether TNF-α contributes to sarcopenia by mediating pyroptosis, one type of PCD. Here, we first established naturally aged mice with sarcopenia model and confirmed an inflammatory state represented by TNF-α in aged mice. Evidence of GSDME-mediated pyroptosis and activation of apoptotic caspase-8/-3 were also found in skeletal muscle cells of aged mice with sarcopenia. We demonstrated that TNF-α triggered GSDME-mediated pyroptosis in myotubes through activating caspase-8 and caspase-3 by using caspase-8 and caspase-3 inhibitors. Comparing the activation of caspase-8 and GSDME expression between TNF Complex IIa and TNF Complex IIb, TNF-α was found to be more inclined to assemble TNF Complex IIb in activating caspase-8 and triggering pyroptosis. Moreover, pyroptotic myotubes were validated to result in decreased expression of MHC1 and finally loss of myotubes by knockdown of GSDME. Our work reveals a novel mechanism that TNF-ɑ/caspase-8/caspase-3/GSDME signaling-mediated pyroptosis contributes to the development of sarcopenia. Caspase-3/GSDME signaling-mediated pyroptosis may be a promising therapeutic target for sarcopenia.
- Open Access
- 23 September 2022
- Published by Springer Nature in Research Square
TNF-α contributes to sarcopenia through caspase-8/caspase-3/GSDME-mediated pyroptosis
Sarcopenia has become a leading cause of disability and mortality in the elderly. Decreased size and loss of the number of skeletal muscle cells are the histological manifestations of sarcopenia. Increasing evidence shows that programmed cell death (PCD) contributes to the loss of skeletal muscle fibers. TNF-α is also validated to play a prominent role in sarcopenia through its complex signaling pathways including cell death signaling. However, it is unclear whether TNF-α contributes to sarcopenia by mediating pyroptosis which is one type of PCD. Here, we first established naturally aged mice with sarcopenia model and confirmed an inflammatory state represented by TNF-α in aged mice. Evidence of GSDME-mediated pyroptosis and activation of apoptotic caspase-8/-3 were further found in skeletal muscle cells. We demonstrated that TNF-α triggered GSDME-mediated pyroptosis in myotubes through activating caspase-8 and caspase-3 by using caspase-8 and caspase-3 inhibitors. Comparing the activation of caspase-8 and GSDME expression between TNF Complex IIa and TNF Complex IIb, TNF-α was more inclined to assemble TNF Complex IIb in activating caspase-8 and triggering pyroptosis. Moreover, pyroptotic myotubes were validated to result in decreased expression of MHC1 and finally loss of myotubes by knockdown of GSDME. Our work unravels a novel mechanism that TNF-ɑ/caspase-8/caspase-3/GSDME signaling-mediated pyroptosis plays a pathogenic role in the development of sarcopenia. caspase-3/GSDME signaling-mediated pyroptosis can be a promising therapeutic target for sarcopenia.
- 23 September 2022
- Published by Springer Nature in Research Square
Open AccessTNF-α contributes to sarcopenia through caspase-8/caspase-3/GSDME-mediated pyroptosis
Sarcopenia has become a leading cause of disability and mortality in the elderly. Decreased size and loss of the number of skeletal muscle cells are the histological manifestations of sarcopenia. Increasing evidence shows that programmed cell death (PCD) contributes to the loss of skeletal muscle fibers. TNF-α is also validated to play a prominent role in sarcopenia through its complex signaling pathways including cell death signaling. However, it is unclear whether TNF-α contributes to sarcopenia by mediating pyroptosis which is one type of PCD. Here, we first established naturally aged mice with sarcopenia model and confirmed an inflammatory state represented by TNF-α in aged mice. Evidence of GSDME-mediated pyroptosis and activation of apoptotic caspase-8/-3 were further found in skeletal muscle cells. We demonstrated that TNF-α triggered GSDME-mediated pyroptosis in myotubes through activating caspase-8 and caspase-3 by using caspase-8 and caspase-3 inhibitors. Comparing the activation of caspase-8 and GSDME expression between TNF Complex IIa and TNF Complex IIb, TNF-α was more inclined to assemble TNF Complex IIb in activating caspase-8 and triggering pyroptosis. Moreover, pyroptotic myotubes were validated to result in decreased expression of MHC1 and finally loss of myotubes by knockdown of GSDME. Our work unravels a novel mechanism that TNF-ɑ/caspase-8/caspase-3/GSDME signaling-mediated pyroptosis plays a pathogenic role in the development of sarcopenia. caspase-3/GSDME signaling-mediated pyroptosis can be a promising therapeutic target for sarcopenia.